1. Home
  2. VERA vs DEI Comparison

VERA vs DEI Comparison

Compare VERA & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • DEI
  • Stock Information
  • Founded
  • VERA 2016
  • DEI 1971
  • Country
  • VERA United States
  • DEI United States
  • Employees
  • VERA N/A
  • DEI N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • DEI Real Estate Investment Trusts
  • Sector
  • VERA Health Care
  • DEI Real Estate
  • Exchange
  • VERA Nasdaq
  • DEI Nasdaq
  • Market Cap
  • VERA 2.0B
  • DEI 2.5B
  • IPO Year
  • VERA 2021
  • DEI 2006
  • Fundamental
  • Price
  • VERA $22.97
  • DEI $15.32
  • Analyst Decision
  • VERA Buy
  • DEI Buy
  • Analyst Count
  • VERA 8
  • DEI 9
  • Target Price
  • VERA $64.63
  • DEI $18.13
  • AVG Volume (30 Days)
  • VERA 2.1M
  • DEI 1.8M
  • Earning Date
  • VERA 08-07-2025
  • DEI 08-05-2025
  • Dividend Yield
  • VERA N/A
  • DEI 4.96%
  • EPS Growth
  • VERA N/A
  • DEI N/A
  • EPS
  • VERA N/A
  • DEI 0.32
  • Revenue
  • VERA N/A
  • DEI $995,663,000.00
  • Revenue This Year
  • VERA N/A
  • DEI $1.10
  • Revenue Next Year
  • VERA N/A
  • DEI $2.30
  • P/E Ratio
  • VERA N/A
  • DEI $48.44
  • Revenue Growth
  • VERA N/A
  • DEI 1.93
  • 52 Week Low
  • VERA $18.53
  • DEI $12.39
  • 52 Week High
  • VERA $51.61
  • DEI $20.50
  • Technical
  • Relative Strength Index (RSI)
  • VERA 49.93
  • DEI 56.63
  • Support Level
  • VERA $22.76
  • DEI $14.75
  • Resistance Level
  • VERA $24.26
  • DEI $15.70
  • Average True Range (ATR)
  • VERA 1.21
  • DEI 0.40
  • MACD
  • VERA 0.11
  • DEI 0.06
  • Stochastic Oscillator
  • VERA 52.74
  • DEI 67.83

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.

Share on Social Networks: